Table I.
Baseline demographic and clinical characteristics of the patients (n=120).
| Variable | n (%) | Average (range) |
|---|---|---|
| Age (years) | 52.5 (21–78)a | |
| ≤60 | 87 (72.5) | |
| >60 | 33 (27.5) | |
| Sex | – | |
| Male | 105 (87.5) | |
| Female | 15 (12.5) | |
| HBsAg status | – | |
| Positive | 83 (72.2) | |
| Negative | 32 (23.4) | |
| HBV DNA status | – | |
| Positive | 39 (40.6) | |
| Negative | 57 (59.4) | |
| Neutrophil count (×109/l) | 3.34±1.73 (0.7–9.1)b | |
| ≤3.3 | 75 (62.5) | |
| >3.3 | 45 (37.5) | |
| Lymphocyte count (×109/l) | 1.12±0.51 (0.2–2.6)b | |
| ≤1.1 | 68 (56.7) | |
| >1.1 | 52 (43.3) | |
| Platelet count (×109/l) | 121.73±72.47 | |
| (23.0–347.0)b | ||
| <125 | 77 (64.2) | |
| ≥125 | 43 (35.8) | |
| Child-Pugh class | – | |
| A | 98 (89.9) | |
| B | 11 (10.1) | |
| α-fetoprotein level (ng/ml) | 10,490.31±19,851.40 | |
| (1.2–60,500.0)b | ||
| ≤20 | 28 (23.3) | |
| >20 | 87 (72.5) | |
| Tumor number | – | |
| <3 | 52 (47.7) | |
| ≥3 | 57 (52.3) | |
| Tumor size (cm) | 42.66±38.99 | |
| (0.0–173.0)b | ||
| ≤5 | 64 (62.7) | |
| >5 | 38 (37.3) | |
| Thrombus | – | |
| Yes | 30 (25.0) | |
| No | 90 (75.0) | |
| Metastasis | – | |
| Yes | 63 (52.5) | |
| No | 57 (47.5) | |
| BCLC stage | – | |
| B | 41 (34.2) | |
| C | 79 (65.8) |
a
Median
b
mean. Certain data were not available for all patients. HBsAg, HBV surface antigen; HBV, hepatitis B virus; BCLC, Barcelona Clinic Liver Cancer.